A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral ABP-745 Administration in Healthy Volunteers
Clinical trial NCT06258213 · COMPLETED
Trial details
- NCT number
- NCT06258213
- Sponsor
- Atom Therapeutics Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-23
- Primary completion
- 2024-07-29
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.